Search Results - "Makoto Nakamuta"

Dietary habits and behaviors associated with nonalcoholic fatty liver disease by Yasutake, Kenichiro, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakashima, Manabu, Nakamuta, Makoto, Enjoji, Munechika

“…Nonalcoholic fatty liver disease(NAFLD)is one of the most frequent causes of health problems in Western(industrialized)countries.Moreover,the incidence of…”
Get full text

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis by Watanabe, Sumio, Hashimoto, Etsuko, Ikejima, Kenichi, Uto, Hirofumi, Ono, Masafumi, Sumida, Yoshio, Seike, Masataka, Takei, Yoshiyuki, Takehara, Tetsuo, Tokushige, Katsutoshi, Nakajima, Atsushi, Yoneda, Masashi, Saibara, Toshiji, Shiota, Goshi, Sakaida, Isao, Nakamuta, Makoto, Mizuta, Toshihiko, Tsubouchi, Hirohito, Sugano, Kentaro, Shimosegawa, Tooru

“…Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a…”
Get full text

Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 by Nakano, Masahito, Yatsuhashi, Hiroshi, Bekki, Shigemune, Takami, Yuko, Tanaka, Yasuhito, Yoshimaru, Yoko, Honda, Koichi, Komorizono, Yasuji, Harada, Masaru, Shibata, Michihiko, Sakisaka, Shotaro, Shakado, Satoshi, Nagata, Kenji, Yoshizumi, Tomoharu, Itoh, Shinji, Sohda, Tetsuro, Oeda, Satoshi, Nakao, Kazuhiko, Sasaki, Ryu, Yamashita, Tsutomu, Ido, Akio, Mawatari, Seiichi, Nakamuta, Makoto, Aratake, Yoshifusa, Matsumoto, Shuichi, Maeshiro, Tatsuji, Goto, Takashi, Torimura, Takuji

“…We examined the epidemiological trends, including the distribution of sex, age, and disease etiology, in HCC incident cases, over 24 years. Data of 20,547 HCC…”
Get full text

Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity by Kubota, Naoto, Kubota, Tetsuya, Kajiwara, Eiji, Iwamura, Tomokatsu, Kumagai, Hiroki, Watanabe, Taku, Inoue, Mariko, Takamoto, Iseki, Sasako, Takayoshi, Kumagai, Katsuyoshi, Kohjima, Motoyuki, Nakamuta, Makoto, Moroi, Masao, Sugi, Kaoru, Noda, Tetsuo, Terauchi, Yasuo, Ueki, Kohjiro, Kadowaki, Takashi

“…Hepatic insulin signalling involves insulin receptor substrates (Irs) 1/2, and is normally associated with the inhibition of gluconeogenesis and activation of…”
Get full text

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis by Watanabe, Sumio, Hashimoto, Etsuko, Ikejima, Kenichi, Uto, Hirofumi, Ono, Masafumi, Sumida, Yoshio, Seike, Masataka, Takei, Yoshiyuki, Takehara, Tetsuo, Tokushige, Katsutoshi, Nakajima, Atsushi, Yoneda, Masashi, Saibara, Toshiji, Shiota, Goshi, Sakaida, Isao, Nakamuta, Makoto, Mizuta, Toshihiko, Tsubouchi, Hirohito, Sugano, Kentaro, Shimosegawa, Tooru

“…Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a…”
Get full text

Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis by Ohno, Akihisa, Fujimori, Nao, Kaku, Toyoma, Takamatsu, Yu, Matsumoto, Kazuhide, Murakami, Masatoshi, Teramatsu, Katsuhito, Takeno, Ayumu, Hijioka, Masayuki, Kawabe, Ken, Harada, Naohiko, Nakamuta, Makoto, Aso, Akira, Oono, Takamasa, Ogawa, Yoshihiro

“…Background Recently, endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) procedures have been gradually established; nonetheless, some adverse events…”
Get full text

A Rare Case of Rheumatoid Arthritis with Tocilizumab-induced Intestinal Mucosal Injury by Ohkubo, Akito, Osoegawa, Takashi, Harada, Naohiko, Iboshi, Yoichiro, Sumida, Yorinobu, Nakamuta, Makoto, Suematsu, Eiichi, Kobayashi, Hiroyuki, Ihara, Eikichi

“…Intestinal mucosal injury that develops as a complication of tocilizumab (TCZ) is usually associated with diverticulosis. We herein report a rare case of…”
Get full text

Over‐the‐catheter endoscope replacement for stenting in patients with inaccessible malignant colonic obstruction with coexisting peritoneal carcinomatosis by Iboshi, Yoichiro, Sumida, Yorinobu, Ihara, Eikichi, Fujii, Hiroyuki, Harada, Naohiko, Nakamuta, Makoto, Ogawa, Yoshihiro

“…Although a large‐caliber endoscope (LCE) is indispensable for through‐the‐scope placement of a self‐expandable metallic stent (SEMS) in patients with malignant…”
Get full text

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study by Ogawa, Eiichi, Furusyo, Norihiro, Nakamuta, Makoto, Nomura, Hideyuki, Satoh, Takeaki, Takahashi, Kazuhiro, Koyanagi, Toshimasa, Kajiwara, Eiji, Dohmen, Kazufumi, Kawano, Akira, Ooho, Aritsune, Azuma, Koichi, Kato, Masaki, Shimoda, Shinji, Hayashi, Jun

“…Aim Glecaprevir (GLE) and pibrentasvir (PIB) are new direct‐acting antiviral agents (DAAs) with pangenotypic inhibitors that respectively target the hepatitis…”
Get full text

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease by Kohjima, Motoyuki, Enjoji, Munechika, Higuchi, Nobito, Kato, Masaki, Kotoh, Kazuhiro, Yoshimoto, Tsuyoshi, Fujino, Tatsuya, Yada, Masayoshi, Yada, Ryoko, Harada, Naohiko, Takayanagi, Ryoichi, Nakamuta, Makoto

“…Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes of abnormal liver dysfunction, and its prevalence has markedly increased. We…”
Get full text

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b by Ogawa, Eiichi, Furusyo, Norihiro, Nomura, Hideyuki, Dohmen, Kazufumi, Higashi, Nobuhiko, Takahashi, Kazuhiro, Kawano, Akira, Azuma, Koichi, Satoh, Takeaki, Nakamuta, Makoto, Koyanagi, Toshimasa, Kato, Masaki, Shimoda, Shinji, Kajiwara, Eiji, Hayashi, Jun

“…Background Little real-world cohort data has been reported for Asians who have received interferon-free regimens with sofosbuvir (SOF) for chronic hepatitis C…”
Get full text

Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? by Enjoji, Munechika, Nakamuta, Makoto

“…In our examination of the distribution of abdominal fat,dietary intake and biochemical data in patients with nonalcoholic fatty liver disease(NAFLD),non-obese…”
Get full text

Importance of preoperative total colonoscopy and endoscopic resection after self-expandable metallic stent placement for obstructive colorectal cancer as a bridge-to-surgery by Itonaga, Shuichi, Hamada, Shohei, Ihara, Eikichi, Honma, Hitoshi, Fukuya, Hiroki, Ookubo, Akito, Sasaki, Taisuke, Yoshimura, Daisuke, Nakamuta, Makoto, Sumida, Yorinobu, Harada, Naohiko

“…Colonic self-expandable metallic stent (SEMS) placement enables preoperative total colonoscopy (TCS) in patients with obstructive colorectal cancer. Following…”
Get full text

Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis by Niizeki, Takashi, Tokunaga, Takayuki, Takami, Yuko, Wada, Yoshiyuki, Harada, Masaru, Shibata, Michihiko, Nakao, Kazuhiko, Sasaki, Ryu, Hirai, Fumihito, Shakado, Satoshi, Yoshizumi, Tomoharu, Itoh, Shinji, Yatsuhashi, Hiroshi, Bekki, Shigemune, Ido, Akio, Mawatari, Seiichi, Honda, Koichi, Sugimoto, Rie, Senju, Takeshi, Takahashi, Hirokazu, Kuwashiro, Takuya, Maeshiro, Tatsuji, Nakamuta, Makoto, Aratake, Yoshifusa, Yamashita, Tsutomu, Otsuka, Yuichiro, Matsumoto, Shuichi, Sohda, Tetsuro, Shimose, Shigeo, Murotani, Kenta, Tanaka, Yasuhito

“…Background A comparison between atezolizumab plus bevacizumab (ATEZO/BEVA) and lenvatinib (LEN) for the treatment of hepatocellular carcinoma (HCC) remains…”
Get full text

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma by Sugimoto, Rie, Motomura, Kenta, Ooho, Aritsune, Aratake, Yoshifusa, Ueda, Akihiro, Senju, Takeshi, Tanaka, Yuki, Yada, Masayoshi, Tanaka, Kohsuke, Kuwano, Akifumi, Morita, Yuusuke, Nagasawa, Shigehiro, Ooe, Mari, Mutsuki, Taiji, Yoshimoto, Tsuyoshi, Yamashita, Naoki, Nakashima, Mai, Hioki, Tomonobu, Koyanagi, Toshimasa, Higuchi, Nobito, Nakamura, Tsukasa, Harada, Shigeru, Tanaka, Masatake, Tada, Seiya, Satoh, Takeaki, Uchimura, Koutarou, Kuniyoshi, Masami, Nakamuta, Makoto, Kohjima, Motoyuki, Liver Disease Investigators' Network of Kyushu University & Surrounding Hospitals (LINKS)

“…Objective Multiple therapeutic agents exist for advanced hepatocellular carcinoma (HCC), but prognostic factors in second-line and subsequent therapies are…”
Get full text

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease by Higuchi, Nobito, Kato, Masaki, Shundo, Yuki, Tajiri, Hirotaka, Tanaka, Masatake, Yamashita, Naoki, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakamuta, Makoto, Takayanagi, Ryoichi, Enjoji, Munechika

“…Aim:  Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes of liver dysfunction and its incidence has increased markedly. However, the…”
Get full text

Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma by Suzuki, Hideo, Kohjima, Motoyuki, Tanaka, Masatake, Goya, Takeshi, Itoh, Shinji, Yoshizumi, Tomoharu, Mori, Masaki, Tsuda, Mariko, Takahashi, Motoi, Kurokawa, Miho, Imoto, Koji, Tashiro, Shigeki, Kuwano, Akifumi, Kato, Masaki, Okada, Seiji, Nakamuta, Makoto, Ogawa, Yoshihiro

“…Objective. Metabolic alteration is widely considered as one of the hallmarks of cancer. Hepatocellular carcinoma (HCC) presents a unique pathological feature…”
Get full text

Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis by Migita, Kiyoshi, Komori, Atsumasa, Kozuru, Hideko, Jiuchi, Yuka, Nakamura, Minoru, Yasunami, Michio, Furukawa, Hiroshi, Abiru, Seigo, Yamasaki, Kazumi, Nagaoka, Shinya, Hashimoto, Satoru, Bekki, Shigemune, Kamitsukasa, Hiroshi, Nakamura, Yoko, Ohta, Hajime, Shimada, Masaaki, Takahashi, Hironao, Mita, Eiji, Hijioka, Taizo, Yamashita, Haruhiro, Kouno, Hiroshi, Nakamuta, Makoto, Ario, Keisuke, Muro, Toyokichi, Sakai, Hironori, Sugi, Kazuhiro, Nishimura, Hideo, Yoshizawa, Kaname, Sato, Takeaki, Naganuma, Atsushi, Komatsu, Tatsuji, Oohara, Yukio, Makita, Fujio, Tomizawa, Minoru, Yatsuhashi, Hiroshi

“…Recent studies have demonstrated that micro (mi)RNA molecules can be detected in the circulation and can serve as potential biomarkers of various diseases…”
Get full text

Gastric cancer presenting with ramucirumab-related gastrocolic fistula successfully managed by colonic stenting: a case report by Fukuya, Hiroki, Iboshi, Yoichiro, Wada, Masafumi, Sumida, Yorinobu, Harada, Naohiko, Nakamuta, Makoto, Fujii, Hiroyuki, Ihara, Eikichi

“…We report a rare case of gastric cancer presenting with a gastrocolic fistula during ramucirumab and paclitaxel combination therapy that was successfully…”
Get full text

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis by Ogawa, Eiichi, Nomura, Hideyuki, Nakamuta, Makoto, Kawano, Akira, Dohmen, Kazufumi, Kajiwara, Eiji, Satoh, Takeaki, Koyanagi, Toshimasa, Takahashi, Kazuhiro, Ooho, Aritsune, Azuma, Koichi, Furusyo, Norihiro, Kato, Masaki, Shimoda, Shinji, Hayashi, Jun

“…Aim Hepatitis C virus genotype 2 is common in East Asia, sub‐Saharan Africa, and Latin America. However, many countries in these areas lag behind other areas…”
Get full text